In a landmark decision for pharmaceutical patent litigation, the Federal Circuit recently affirmed the validity of U.S. Patent No. 9,439,906 (“the ’906 patent”) in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Nos. 25-1228, 25-1252...
